Table 3.

Major cardiovascular events of both groups after one year of follow up.

	GROUP I (N = 842) (CONTROLLED HTN)	GROUP II (N = 148)(RESISTANT HTN)	P. VALUE
Mortality, n (%)	6 (0.7%)	2 (1.4%)	0.423
New onset atrial fibrillation, n (%)	21 (2.5%)	10 (6.8%)	0.006*
Transient ischemic attacks, n (%)	12 (1.4%)	5 (3.4%)	0.092
Cerebral stroke, n (%)	10 (1.2%)	6 (4.1%)	0.011*
Cerebral hemorrhage, n (%)	7 (0.8%)	3 (2.0%)	0.180
Unstable angina, n (%)	25 (3.0%)	9 (6.1%)	0.055
Myocardial infarction, n (%)	11 (1.3%)	7 (4.7%)	0.004*
Acute peripheral vascular ischemia, n (%)	9 (1.1%)	4 (2.7%)	0.107
Acute heart failure, n (%)	15 (1.8%)	7 (4.7%)	0.025*

*: Significant P value.